I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
A Study of Avelumab In Combination With Axitinib in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumor After Failure of Standard Therapy
To assess anti-tumor activity of avelumab in combination with axitinib in patients with unresectable/metastatic GIST after progression on second or third line treatment (after failure on at least of imatinib and sunitinib) in terms of progression-free survival (PFS)
glomerular filtration rate
immunohistochemistry
stromal tumor
avelumab
gastrointestinal stromal tumor
- 0 views
- 19 Feb, 2024